MeVis Medical Solutions AG (FRA:M3V)

Market Cap	45.14M -2.4%
Revenue (ttm)	16.06M -5.4%
Net Income	3.17M -30.6%
EPS	1.74 -30.6%
Shares Out	n/a
PE Ratio	14.26
Forward PE	n/a
Dividend	0.95 (3.89%)
Ex-Dividend Date	Mar 20, 2026

Volume	1
Average Volume	0
Open	23.80
Previous Close	24.60
Day's Range	23.80 - 24.40
52-Week Range	22.60 - 26.40
Beta	n/a
RSI	45.85
Earnings Date	Jan 29, 2026

About FRA:M3V

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sono...

• Industry: Prepackaged Software
• Founded: 1997
• Employees: 112
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: M3V

Financial Performance

In fiscal year 2025, FRA:M3V's revenue was 16.06 million, a decrease of -5.36% compared to the previous year's 16.97 million. Earnings were 3.17 million, a decrease of -30.58%.